The short answer
Folic acid can lower phenytoin levels in some people, but it may also be needed to treat deficiency or support pregnancy care. These products can be used together with a prescriber-led monitoring plan. Do not independently start, stop or change either treatment.
What this answer covers
Folic acid with oral phenytoin; folate status, pregnancy needs, formulation and individual seizure control matter.
- Supplement or preparation
- Folic acid
- Medication ingredient
- phenytoin
The interaction can be clinically relevant
Small studies and an individual case report found lower phenytoin levels after folic acid was added; one patient lost seizure control. Concentration changes may involve metabolism rather than reduced gut absorption. The evidence does not establish the same response for everyone.
Supplementation can also have benefits
Phenytoin can reduce folate status, and replacement may be needed. A small crossover study improved folate without a clear phenytoin-level difference. A separate pediatric trial reduced gum overgrowth. These benefits support managed co-use rather than blanket avoidance.
Starting and stopping both deserve a plan
The clinician may compare phenytoin levels before and after folic acid changes and adjust treatment if needed. Stopping folic acid can also matter if the medication dose was raised during supplementation. Dose separation is not an established way to prevent a metabolic interaction.
Pregnancy and deficiency need individualized care
If pregnant or planning pregnancy, discuss folate and the seizure regimen with a specialist. Do not omit needed folic acid because of this warning or change phenytoin without advice. The appropriate dose and follow-up depend on your reason for treatment and clinical history.
Evidence and practical considerations
Absorption & effectiveness
Folic acid can lower phenytoin levels in some people, but it may also be needed to treat deficiency or support pregnancy care. These products can be used together with a prescriber-led monitoring plan. Do not independently start, stop or change either treatment.
- Exact scope
- Folic acid with oral phenytoin; folate status, pregnancy needs, formulation and individual seizure control matter. with Oral phenytoin; free-acid and sodium-salt formulations are explicitly distinguished.
- Medication form and route
- oral
What remains uncertain
- No universal risk rate or dose interval is established. Specific original-source limitations and access status are documented.
Factors that may matter: Exact preparation and amount; Medication formulation and drug levels; Seizure history and other treatments.
Read the supporting source summaries
Source 1: Current U.S. regulatory labeling
dailymed.nlm.nih.gov · Source check Sep 10, 2026
Population: People prescribed oral phenytoin for supported seizure indications.
Labels name folic acid and St John’s wort as possible causes of lower phenytoin levels. Calcium-carbonate and magnesium-hydroxide antacids should not be taken simultaneously. Abrupt withdrawal can worsen seizures.
How this applies: Exact medication precautions with the formulation bridge explicitly retained.
A generic mineral is not every antacid salt. Free-acid and sodium formulations have different drug content; oral absorption findings do not apply to intravenous administration.
Source 2: Original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Four folate-deficient men with epilepsy using phenytoin alone.
Phenytoin levels fell in three participants, with metabolic measurements suggesting increased oxidative metabolism.
How this applies: Direct evidence of concentration changes during replacement, requiring an individual plan.
Tiny uncontrolled study in deficient patients. Does not establish a uniform effect, a dose threshold or impaired intestinal absorption.
Source 3: Original clinical case report
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: One folate-deficient man with epilepsy.
Seizures increased and medication adjustment was needed to regain control.
How this applies: Shows that clinically relevant loss of control can occur, including at a dose below many pharmacologic regimens.
Single report, no incidence estimate or proof that every patient responds similarly.
Source 4: Original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: Six women of childbearing age in a randomized crossover.
Folate levels improved with supplementation; phenytoin concentrations were similar across treatments.
How this applies: Preserves a null concentration result and a reason folate replacement can be beneficial.
Small study and differing attainment of steady state. Does not eliminate the interaction seen in some deficient patients.
Source 5: Original human study
pubmed.ncbi.nlm.nih.gov · Source check Sep 10, 2026
Population: 120 children aged 6-15 recently started on phenytoin monotherapy.
Gingival overgrowth was less frequent with folic acid.
How this applies: Supports potential benefit without making a personal dosing recommendation.
Primary outcome was gum overgrowth, not an exact interaction risk estimate for adults. Original abstract available; full-text retrieval was blocked.
Source 6: NHS specialist pharmacy guidance
sps.nhs.uk · Source check Sep 10, 2026
Population: People who need both phenytoin and folic acid.
Co-use is possible with drug-level monitoring and prescriber-led adjustment when folic acid starts or stops.
How this applies: Balances replacement benefits with concentration and seizure-control risks.
Dose and follow-up depend on the patient; this is UK professional guidance rather than a trial.
Research assessment: · Open full citations ↗
Review and change history
- Publication status
- Published research summary
- Clinical review
- Not yet recorded
| Date | Update |
|---|---|
| Article prepared | |
| Initial source-checked research draft with exact formulation limits, contrary evidence and source-access details. Clinical review not recorded. | |
| Research summary published |
Article revision: 0fe18a2c6430f08f
This guide brings together the evidence records used by our interaction checker. Each finding retains its own preparation limits, research date, and source summaries.
Full citations require verification. Reading this answer and the source summaries does not.
Taking other supplements or medications?
Use the checker to explore your other combinations. Ask a pharmacist to review the exact products, amounts and medical conditions in your complete list.
Open the interaction checkerInformation, not medical advice. Do not change prescribed treatment based on this guide.